SS
ALXN

Steve Schonfeld’s Alexion Pharmaceuticals ALXN Stock Holding History

Steve Schonfeld’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-193,900
Closed -$35.6M – 2680
2021
Q2 		$35.6M Buy
193,900
+86,093
+80% +$14.8M 0.38% 41
2021
Q1 		$16.5M Buy
107,807
+23,892
+28% +$3.7M 0.2% 125
2020
Q4 		$13.1M Buy
83,915
+69,548
+484% +$8.94M 0.18% 157
2020
Q3 		$1.64M Sell
14,367
-10,174
-41% -$1.1M 0.03% 564
2020
Q2 		$2.75M Buy
24,541
+9,269
+61% +$984K 0.07% 338
2020
Q1 		$1.37M Buy
15,272
+5,265
+53% +$517K 0.09% 280
2019
Q4 		$1.08M Sell
10,007
-44,631
-82% -$4.77M 0.03% 489
2019
Q3 		$5.35M Buy
54,638
+45,960
+530% +$5.18M 0.16% 165
2019
Q2 		$1.14M Buy
8,678
+6,703
+339% +$864K 0.04% 416
2019
Q1 		$267K Sell
1,975
-19,299
-91% -$2.4M 0.01% 865
2018
Q4 		$2.07M Sell
21,274
-19,926
-48% -$2.36M 0.08% 318
2018
Q3 		$5.73M Buy
41,200
+6,200
+18% +$778K 0.25% 116
2018
Q2 		$4.34M Sell
35,000
-3,451
-9% -$403K 0.24% 149
2018
Q1 		$4.29M Buy
38,451
+5,906
+18% +$706K 0.32% 86
2017
Q4 		$3.89M Buy
32,545
+7,108
+28% +$866K 0.32% 90
2017
Q3 		$3.57M Buy
25,437
+10,897
+75% +$1.48M 0.33% 101
2017
Q2 		$1.77M Sell
14,540
-2,495
-15% -$290K 0.18% 171
2017
Q1 		$2.06M Sell
17,035
-19,119
-53% -$2.46M 0.21% 137
2016
Q4 		$4.42M Buy
+36,154
New +$4.42M 0.57% 40
2016
Q3 		– Sell
-46,768
Closed -$5.46M – 593
2016
Q2 		$5.46M Buy
46,768
+43,768
+1,459% +$6.21M 1.22% 10
2016
Q1 		$418K Buy
+3,000
New +$440K 0.17% 152

Other funds holding ALXN

BCI
Brinker Capital Investments Berwyn, Pennsylvania $13.1B AUM 28.37% 1-Year Est. Return
NICM
Neo Ivy Capital Management New York $434M AUM 44.19% 1-Year Est. Return
TAIM
TD Ameritrade Investment Management Omaha, Nebraska $9.4B AUM 7.2% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return
RG
Retirement Group San Diego, California $279M AUM 22.21% 1-Year Est. Return
CFO
CVA Family Office Denver, Colorado $1.1B AUM 26.6% 1-Year Est. Return
MAM
Meeder Asset Management Dublin, Ohio $1.96B AUM 48.96% 1-Year Est. Return

Steve Schonfeld's ALXN Position: Q3 2021 in Review

Steve Schonfeld sold out of Alexion Pharmaceuticals (ALXN) in Q3 2021, closing a stake of 193,900 shares — an estimated $35.6M sold.

Steve Schonfeld first reported a position in ALXN in Q1 2016 and held it in 21 quarters. The position peaked at $35.6M in Q2 2021. 7 funds tracked by Wall St. Rank hold ALXN as of Q3 2021.

  • Steve Schonfeld reported no remaining Alexion Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
  • Steve Schonfeld sold 193,900 Alexion Pharmaceuticals shares in Q3 2021, an estimated $35.6M.
  • Steve Schonfeld first reported a position in Alexion Pharmaceuticals in Q1 2016 and held it in 21 quarters.
  • Steve Schonfeld's Alexion Pharmaceuticals position peaked at $35.6M in Q2 2021.
  • 7 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q3 2021.

Based on Schonfeld Strategic Advisors's 13F filing for Q3 2021, filed 16 Nov 2021.